Adrecizumab, a non-neutralizing anti-adrenomedullin antibody, improves haemodynamics and attenuates myocardial oxidative stress in septic rats.

Adrecizumab injection also tended to improve diastolic and mean blood pressures and LV shortening fraction, although these did not reach statistical significance due to a possible type 2 error (Fig. 2 ).

also in 111,027 other papers